Global Drug Repurposing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 13-Sep-2018
No. of pages: 115

Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to bedside. Drug repurposing opens up various opportunities to answer current unmet medical needs to come up with cost-effective solutions to expensive drug development process. Repurposing or re-profiling of drugs which are suspended due to lack of efficacy or specificity can be a good start over for further development for new indication. Finding new indications for already studied drugs can benefit patients by getting quick access to new treatment choices and also to developer by saving time and money while maintaining its original IP protection. For many expensive indications such as cancer, scrutinizing for anti-cancer activity among dozens of off-patent drugs that have already established their safety is a powerful method opted by majority of the big pharma companies. However, repurposing is not a new strategy and there are bunch of drugs which are repositioned or repurposed, some of them are Raloxifene (approved for treatment of osteoporosis in 2007, originally indicated for breast cancer treatment), Thalidomide (repositioned for use in treatment of leprosy and multiple myeloma in 2006), Rapamycin (repurposed in 1999 for prevention of organ transplant rejection), Sildenafil (originally approved for erectile dysfunction and recently got approved for treatment of angina) and many others.

Scope of the Report:

This report focuses on the Drug Repurposing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Requirement of low investment of time and money in the drug development is the prime advantage of drug repurposing and majority of the drugs in pipeline of major pharmaceutical companies are thus adopt this method. Some of the factors accelerating the drug repurposing activities include sunk research cost, ready availably of bioavailability, pharmacology, toxicity profile & pharmacokinetics data, well established manufacturing protocol etc.; which are expected to drive the global drug repurposing market. There are thousands of failed molecules shelved into the drug libraries, which hold vast potential to reposition. Whereas, limited access chemical structure data of drug molecules, lack of funding etc. are some of the factors limiting the growth of global drug repurposing market.

The worldwide market for Drug Repurposing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

-Astellas Pharma

-Biovista

-Novartis

-AbbVie

-Pfizer

-Allergan

-NuMedii

Market Segment by Regions, regional analysis covers

-North America (United States, Canada and Mexico)

-Europe (Germany, France, UK, Russia and Italy)

-Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

-South America (Brazil, Argentina, Colombia etc.)

-Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

-Oncology

-CNS Diseases

-Neurodegenerative Diseases

-Others

Market Segment by Applications, can be divided into

-Hospitals

-Ambulatory Surgical Centers

-Others

There are 15 Chapters to deeply display the global Drug Repurposing market.

Chapter 1, to describe Drug Repurposing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Drug Repurposing, with sales, revenue, and price of Drug Repurposing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Drug Repurposing, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Drug Repurposing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Drug Repurposing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Drug Repurposing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Drug Repurposing Introduction
1.2 Market Analysis by Type
1.2.1 Oncology
1.2.2 CNS Diseases
1.2.3 Neurodegenerative Diseases
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Business Overview
2.1.2 Drug Repurposing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astellas Pharma Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Biovista
2.2.1 Business Overview
2.2.2 Drug Repurposing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biovista Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Drug Repurposing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AbbVie
2.4.1 Business Overview
2.4.2 Drug Repurposing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Drug Repurposing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Allergan
2.6.1 Business Overview
2.6.2 Drug Repurposing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Allergan Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 NuMedii
2.7.1 Business Overview
2.7.2 Drug Repurposing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 NuMedii Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Drug Repurposing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Drug Repurposing Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drug Repurposing Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Drug Repurposing Manufacturer Market Share in 2017
3.3.2 Top 6 Drug Repurposing Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Drug Repurposing Market Analysis by Regions
4.1 Global Drug Repurposing Sales, Revenue and Market Share by Regions
4.1.1 Global Drug Repurposing Sales and Market Share by Regions (2013-2018)
4.1.2 Global Drug Repurposing Revenue and Market Share by Regions (2013-2018)
4.2 North America Drug Repurposing Sales and Growth Rate (2013-2018)
4.3 Europe Drug Repurposing Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Drug Repurposing Sales and Growth Rate (2013-2018)
4.5 South America Drug Repurposing Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Drug Repurposing Sales and Growth Rate (2013-2018)
5 North America Drug Repurposing by Countries
5.1 North America Drug Repurposing Sales, Revenue and Market Share by Countries
5.1.1 North America Drug Repurposing Sales and Market Share by Countries (2013-2018)
5.1.2 North America Drug Repurposing Revenue and Market Share by Countries (2013-2018)
5.2 United States Drug Repurposing Sales and Growth Rate (2013-2018)
5.3 Canada Drug Repurposing Sales and Growth Rate (2013-2018)
5.4 Mexico Drug Repurposing Sales and Growth Rate (2013-2018)
6 Europe Drug Repurposing by Countries
6.1 Europe Drug Repurposing Sales, Revenue and Market Share by Countries
6.1.1 Europe Drug Repurposing Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Drug Repurposing Revenue and Market Share by Countries (2013-2018)
6.2 Germany Drug Repurposing Sales and Growth Rate (2013-2018)
6.3 UK Drug Repurposing Sales and Growth Rate (2013-2018)
6.4 France Drug Repurposing Sales and Growth Rate (2013-2018)
6.5 Russia Drug Repurposing Sales and Growth Rate (2013-2018)
6.6 Italy Drug Repurposing Sales and Growth Rate (2013-2018)
7 Asia-Pacific Drug Repurposing by Countries
7.1 Asia-Pacific Drug Repurposing Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drug Repurposing Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Drug Repurposing Revenue and Market Share by Countries (2013-2018)
7.2 China Drug Repurposing Sales and Growth Rate (2013-2018)
7.3 Japan Drug Repurposing Sales and Growth Rate (2013-2018)
7.4 Korea Drug Repurposing Sales and Growth Rate (2013-2018)
7.5 India Drug Repurposing Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Drug Repurposing Sales and Growth Rate (2013-2018)
8 South America Drug Repurposing by Countries
8.1 South America Drug Repurposing Sales, Revenue and Market Share by Countries
8.1.1 South America Drug Repurposing Sales and Market Share by Countries (2013-2018)
8.1.2 South America Drug Repurposing Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Drug Repurposing Sales and Growth Rate (2013-2018)
8.3 Argentina Drug Repurposing Sales and Growth Rate (2013-2018)
8.4 Colombia Drug Repurposing Sales and Growth Rate (2013-2018)
9 Middle East and Africa Drug Repurposing by Countries
9.1 Middle East and Africa Drug Repurposing Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drug Repurposing Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Drug Repurposing Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Drug Repurposing Sales and Growth Rate (2013-2018)
9.3 UAE Drug Repurposing Sales and Growth Rate (2013-2018)
9.4 Egypt Drug Repurposing Sales and Growth Rate (2013-2018)
9.5 Nigeria Drug Repurposing Sales and Growth Rate (2013-2018)
9.6 South Africa Drug Repurposing Sales and Growth Rate (2013-2018)
10 Global Drug Repurposing Market Segment by Type
10.1 Global Drug Repurposing Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drug Repurposing Sales and Market Share by Type (2013-2018)
10.1.2 Global Drug Repurposing Revenue and Market Share by Type (2013-2018)
10.2 Oncology Sales Growth and Price
10.2.1 Global Oncology Sales Growth (2013-2018)
10.2.2 Global Oncology Price (2013-2018)
10.3 CNS Diseases Sales Growth and Price
10.3.1 Global CNS Diseases Sales Growth (2013-2018)
10.3.2 Global CNS Diseases Price (2013-2018)
10.4 Neurodegenerative Diseases Sales Growth and Price
10.4.1 Global Neurodegenerative Diseases Sales Growth (2013-2018)
10.4.2 Global Neurodegenerative Diseases Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Drug Repurposing Market Segment by Application
11.1 Global Drug Repurposing Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Ambulatory Surgical Centers Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Drug Repurposing Market Forecast (2018-2023)
12.1 Global Drug Repurposing Sales, Revenue and Growth Rate (2018-2023)
12.2 Drug Repurposing Market Forecast by Regions (2018-2023)
12.2.1 North America Drug Repurposing Market Forecast (2018-2023)
12.2.2 Europe Drug Repurposing Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drug Repurposing Market Forecast (2018-2023)
12.2.4 South America Drug Repurposing Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drug Repurposing Market Forecast (2018-2023)
12.3 Drug Repurposing Market Forecast by Type (2018-2023)
12.3.1 Global Drug Repurposing Sales Forecast by Type (2018-2023)
12.3.2 Global Drug Repurposing Market Share Forecast by Type (2018-2023)
12.4 Drug Repurposing Market Forecast by Application (2018-2023)
12.4.1 Global Drug Repurposing Sales Forecast by Application (2018-2023)
12.4.2 Global Drug Repurposing Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Drug Repurposing Picture
Table Product Specifications of Drug Repurposing
Figure Global Sales Market Share of Drug Repurposing by Types in 2017
Table Drug Repurposing Types for Major Manufacturers
Figure Oncology Picture
Figure CNS Diseases Picture
Figure Neurodegenerative Diseases Picture
Figure Others Picture
Figure Drug Repurposing Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Others Picture
Figure United States Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure France Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure UK Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure China Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure India Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Drug Repurposing Revenue (Value) and Growth Rate (2013-2023)
Table Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Drug Repurposing Type and Applications
Table Astellas Pharma Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biovista Basic Information, Manufacturing Base and Competitors
Table Biovista Drug Repurposing Type and Applications
Table Biovista Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Drug Repurposing Type and Applications
Table Novartis Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Drug Repurposing Type and Applications
Table AbbVie Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drug Repurposing Type and Applications
Table Pfizer Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Drug Repurposing Type and Applications
Table Allergan Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table NuMedii Basic Information, Manufacturing Base and Competitors
Table NuMedii Drug Repurposing Type and Applications
Table NuMedii Drug Repurposing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Drug Repurposing Sales by Manufacturer (2016-2017)
Figure Global Drug Repurposing Sales Market Share by Manufacturer in 2016
Figure Global Drug Repurposing Sales Market Share by Manufacturer in 2017
Table Global Drug Repurposing Revenue by Manufacturer (2016-2017)
Figure Global Drug Repurposing Revenue Market Share by Manufacturer in 2016
Figure Global Drug Repurposing Revenue Market Share by Manufacturer in 2017
Figure Top 3 Drug Repurposing Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Drug Repurposing Manufacturer (Revenue) Market Share in 2017
Figure Global Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Global Drug Repurposing Revenue and Growth Rate (2013-2018)
Table Global Drug Repurposing Sales by Regions (2013-2018)
Table Global Drug Repurposing Sales Market Share by Regions (2013-2018)
Table Global Drug Repurposing Revenue by Regions (2013-2018)
Figure Global Drug Repurposing Revenue Market Share by Regions in 2013
Figure Global Drug Repurposing Revenue Market Share by Regions in 2017
Figure North America Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Europe Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drug Repurposing Sales and Growth Rate (2013-2018)
Figure South America Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drug Repurposing Sales and Growth Rate (2013-2018)
Figure North America Drug Repurposing Revenue and Growth Rate (2013-2018)
Table North America Drug Repurposing Sales by Countries (2013-2018)
Table North America Drug Repurposing Sales Market Share by Countries (2013-2018)
Figure North America Drug Repurposing Sales Market Share by Countries in 2013
Figure North America Drug Repurposing Sales Market Share by Countries in 2017
Table North America Drug Repurposing Revenue by Countries (2013-2018)
Table North America Drug Repurposing Revenue Market Share by Countries (2013-2018)
Figure North America Drug Repurposing Revenue Market Share by Countries in 2013
Figure North America Drug Repurposing Revenue Market Share by Countries in 2017
Figure United States Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Canada Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Mexico Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Europe Drug Repurposing Revenue and Growth Rate (2013-2018)
Table Europe Drug Repurposing Sales by Countries (2013-2018)
Table Europe Drug Repurposing Sales Market Share by Countries (2013-2018)
Table Europe Drug Repurposing Revenue by Countries (2013-2018)
Figure Europe Drug Repurposing Revenue Market Share by Countries in 2016
Figure Europe Drug Repurposing Revenue Market Share by Countries in 2017
Figure Germany Drug Repurposing Sales and Growth Rate (2013-2018)
Figure UK Drug Repurposing Sales and Growth Rate (2013-2018)
Figure France Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Russia Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Italy Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drug Repurposing Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Drug Repurposing Sales by Countries (2013-2018)
Table Asia-Pacific Drug Repurposing Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Drug Repurposing Sales Market Share by Countries 2017
Table Asia-Pacific Drug Repurposing Revenue by Countries (2013-2018)
Figure Asia-Pacific Drug Repurposing Revenue Market Share by Countries 2017
Figure China Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Japan Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Korea Drug Repurposing Sales and Growth Rate (2013-2018)
Figure India Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Southeast Asia Drug Repurposing Sales and Growth Rate (2013-2018)
Figure South America Drug Repurposing Revenue and Growth Rate (2013-2018)
Table South America Drug Repurposing Sales by Countries (2013-2018)
Table South America Drug Repurposing Sales Market Share by Countries (2013-2018)
Figure South America Drug Repurposing Sales Market Share by Countries in 2017
Table South America Drug Repurposing Revenue by Countries (2013-2018)
Table South America Drug Repurposing Revenue Market Share by Countries (2013-2018)
Figure South America Drug Repurposing Revenue Market Share by Countries in 2017
Figure Brazil Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Argentina Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Colombia Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drug Repurposing Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Drug Repurposing Sales by Countries (2013-2018)
Table Middle East and Africa Drug Repurposing Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Drug Repurposing Sales Market Share by Countries in 2017
Table Middle East and Africa Drug Repurposing Revenue by Countries (2013-2018)
Table Middle East and Africa Drug Repurposing Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2013
Figure Middle East and Africa Drug Repurposing Revenue Market Share by Countries in 2017
Figure Saudi Arabia Drug Repurposing Sales and Growth Rate (2013-2018)
Figure UAE Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Egypt Drug Repurposing Sales and Growth Rate (2013-2018)
Figure Nigeria Drug Repurposing Sales and Growth Rate (2013-2018)
Figure South Africa Drug Repurposing Sales and Growth Rate (2013-2018)
Table Global Drug Repurposing Sales by Type (2013-2018)
Table Global Drug Repurposing Sales Share by Type (2013-2018)
Table Global Drug Repurposing Revenue by Type (2013-2018)
Table Global Drug Repurposing Revenue Share by Type (2013-2018)
Figure Global Oncology Sales Growth (2013-2018)
Figure Global Oncology Price (2013-2018)
Figure Global CNS Diseases Sales Growth (2013-2018)
Figure Global CNS Diseases Price (2013-2018)
Figure Global Neurodegenerative Diseases Sales Growth (2013-2018)
Figure Global Neurodegenerative Diseases Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Drug Repurposing Sales by Application (2013-2018)
Table Global Drug Repurposing Sales Share by Application (2013-2018)
Figure Global Ambulatory Surgical Centers Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Drug Repurposing Sales, Revenue and Growth Rate (2018-2023)
Table Global Drug Repurposing Sales Forecast by Regions (2018-2023)
Table Global Drug Repurposing Market Share Forecast by Regions (2018-2023)
Figure North America Sales Drug Repurposing Market Forecast (2018-2023)
Figure Europe Sales Drug Repurposing Market Forecast (2018-2023)
Figure Asia-Pacific Sales Drug Repurposing Market Forecast (2018-2023)
Figure South America Sales Drug Repurposing Market Forecast (2018-2023)
Figure Middle East and Africa Sales Drug Repurposing Market Forecast (2018-2023)
Table Global Drug Repurposing Sales Forecast by Type (2018-2023)
Table Global Drug Repurposing Market Share Forecast by Type (2018-2023)
Table Global Drug Repurposing Sales Forecast by Application (2018-2023)
Table Global Drug Repurposing Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Viral Conjunctivitis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 25-Sep-2018        Price: US 3480 Onwards        Pages: 121
    Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely to exhibit a thumping CAGR of 69.60% between 2020 and 2023 and reach an opportunity worth US$462.4 mn by the end of the forecast period. Scope of the Report: This report f......
  • Global Vitamin B-complex Ingredients Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 25-Sep-2018        Price: US 3480 Onwards        Pages: 135
    Vitamins are organic compounds that are required by living organisms in minute quantities to maintain a normal metabolic activity. These compounds usually cannot be synthesized by the organism and have to be obtained through external sources. The term "vitamin" is a generic descriptor for a group of chemical compounds or ingredients that have similar molecular structure and have the capability to perform the required vitamin-activity. These chemical compounds or vitamin ingredients are often cal......
  • Global Secondary Oral Hygiene Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 25-Sep-2018        Price: US 3480 Onwards        Pages: 137
    Secondary oral hygiene can be described as the usage of products for the protection of gums from periodontal diseases. It includes mouthwashes, dental flosses, mouth fresheners, teeth whitening products, and mouth dentures. Scope of the Report: This report focuses on the Secondary Oral Hygiene Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacture......
  • Global Vaginal Odor Control Product Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 25-Sep-2018        Price: US 3480 Onwards        Pages: 101
    One of the most commonly occurring and least talked about feminine concerns is vaginal odor. Every woman has a unique scent that fluctuates during her menstrual cycle and may change depending upon hormone levels. The scent originates from vaginal secretions and can vary throughout the month. Scope of the Report: This report focuses on the Vaginal Odor Control Product in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East a......
  • Global Sexual Wellness Products Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Sexual wellness refers to the physical, mental, and sexual well-being of people. Products such as erotic lingerie, condoms and contraceptives, personal lubricants, sex toys, and others such as testing cards and pregnancy testing kits, sexual enhancement supplements, sex games, and vaginal sexual wellness products, which enhance safety and pleasure of sexual experiences, are considered sexual wellness products. Scope of the Report: This report focuses on the Sexual Wellness ......
  • Global Etoposide Market Insights, Forecast to 2025
    Published: 24-Sep-2018        Price: US 3900 Onwards        Pages: 118
    This report studies the global market size of Etoposide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Etoposide in these regions. This research report categorizes the global Etoposide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, ......
  • Global Oseltamivir Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 102
    Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B (flu). Scope of the Report: This report focuses on the Oseltamivir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The worldwide market for Oseltamivir is expected to grow at a CAGR of roug......
  • Global Over The Counter (OTC) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 119
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Scope of the Report: This report focuses on the Over The Counter (OTC) Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, re......
  • Global Over the Counter (OTC) Drugs & Dietary Supplements Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 24-Sep-2018        Price: US 3480 Onwards        Pages: 136
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements. Scope of the Report:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs